Last reviewed · How we verify

NCT04220710

cfDNA in Diagnosis and Differential Diagnosis of Ovarian Endometriosis

Status unknown Last updated 7 January 2020
What this trial tests

trial testing DNA extraction and methylation detection in Circulating Free DNA in 390 participants. Status unknown.

Timeline
20 August 2019
Primary endpoint
20 February 2020
20 August 2020

Quick facts

Lead sponsorPeking Union Medical College Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment390
Start date20 August 2019
Primary completion20 February 2020
Estimated completion20 August 2020
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking Union Medical College Hospital

Who can join

18 and older, female only, with Circulating Free DNA. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Methylation detection of circulating free DNA to identify markers for diagnosis and differential diagnosis of ovarian endometriosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04220710.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing